{
    "name": "edaravone",
    "comment": "Rx",
    "other_names": [
        "Radicava",
        "Radicava ORS"
    ],
    "classes": [
        "Neurologics",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/radicava-radicava-ors-edaravone-1000140",
    "pregnancy": {
        "common": [
            "There are no adequate data on the developmental risk associated with use in pregnant women",
            "In animal studies, administration to pregnant rats and rabbits resulted in adverse developmental effects (increased mortality, decreased growth, delayed sexual development, and altered behavior) at clinically relevant doses; most of these effects occurred at doses that were also associated with maternal toxicity"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk",
            "Excreted in the milk of lactating rats",
            "Consider the developmental and health benefits of breastfeeding along with the motherâ€™s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to drug or any of its excipients"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Hypersensitivity reactions (redness, wheals, and erythema multiforme) and cases of anaphylaxis (urticaria, decreased blood pressure, and dyspnea) reported; monitor for hypersensitivity reactions; if hypersensitivity reactions occur, discontinue drug, treat per standard of care, and monitor until condition resolves",
                "Contains sodium bisulfite, which may cause allergic type-reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in susceptible people; sulfite sensitivity occurs more often with history of asthma"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Contusion",
            "percent": "15"
        },
        {
            "name": "Gait disturbance",
            "percent": "13"
        },
        {
            "name": "Headache",
            "percent": "10"
        },
        {
            "name": "Dermatitis",
            "percent": "8"
        },
        {
            "name": "Eczema",
            "percent": "7"
        },
        {
            "name": "Respiratory failure",
            "percent": "6"
        },
        {
            "name": "respiratory disorder",
            "percent": "4"
        },
        {
            "name": "hypoxia",
            "percent": "4"
        },
        {
            "name": "Glycosuria",
            "percent": null
        },
        {
            "name": "Tinea infection",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions and anaphylaxis",
            "percent": null
        }
    ]
}